Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
First gene therapy for rare subtype of Charcot-Marie-Tooth disease clears hurdle
Positive results from Crohn’s disease trial
Crystalys Therapeutics launches with $205m to take on gout
New radiopharmaceutical preclinical CRO created
JV to develop small molecule targeting DNA damage response in glioblastoma
Tumour cells exploit damaged tissue in the pancreas
Imlifidase successfully meets primary kidney transplantation endpoint
Base to Base biotech podcast 29: Blood pressure and radiopharmaceuticals